Published On: March 18th, 2024Categories:

Many of our clients asked our opinion on the Pharma-Biopharma sector. In this report, we take a closer look at the trends actually shaping the pharma industry, the major risks and opportunities inside this (defensive) sector, and what are in our view the best candidates to play this thematic. At the end of the report, you can find a more detailed analysis of the issuers that we have selected (top picks) – AbbVie, Amgen, AstraZeneca, Pfizer, Roche and Novo Nordisk – and a list of their bonds.

Don’t miss our latest publication! Discover us on

Share this article :